Navigation Links
Debate Over Advertising Prescription Drugs to Consumers Goes Online at New ProCon.org Website
Date:7/17/2009

SANTA MONICA, Calif., July 17 /PRNewswire-USNewswire/ -- ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website www.prescriptiondrugs.procon.org to explore the core question "Should prescription drugs be advertised directly to consumers?"

Hundreds of often conflicting studies and articles have been published on whether direct to consumer (DTC) prescription drug ads help or harm public health. ProCon.org has reviewed much of this information and condensed it into a straightforward nonpartisan pro and con presentation.

Proponents of DTC prescription drug ads argue that the ads provide an educational benefit, encourage doctor visitation, reduce stigmas associated with certain medical conditions, comply with all laws, and encourage new drug development by helping to keep pharmaceutical companies profitable.

Opponents argue that DTC prescription drug ads persuade vs. educate, lead to hypochondria and overmedication, raise drug prices, and generally jeopardize public health by replacing medical information with marketing information.

The site's purpose is to help people think critically about this topic so they can make better decisions about DTC prescription drug advertising. The site contains a "Did You Know?" section, an overview of the issue, pro and con arguments, an image and video gallery, a reader survey, and a listing of all sources used.

Some interesting information presented on the website includes:

* Bayer Pharmaceuticals sold heroin as an over the counter cough remedy in the early 1900s.

* The Food and Drug Administration began regulating prescription drug advertising in 1962.

* Every $1.00 spent on DTC prescription drug advertising yields about $4.20 in that drug's sales.

* In 2007, the pharmaceutical industry was estimated to be spending $4.8 billion annually in DTC prescription drug advertising.

* In 2008, the pharmaceutical industry was estimated to be a $291 billion industry.

About Us

ProCon.org is a 501(c)3 nonprofit public charity whose mission is "Promoting critical thinking, education, and informed citizenship by presenting controversial issues in a straightforward, nonpartisan primarily pro-con format."

All 21 ProCon.org websites are free of charge, require no registration, and contain no advertising. The websites have been referenced by over 120 media entities and used in over 540 schools in 48 states and 14 countries.

To see all ProCon.org topics, including prescription drug advertising, visit www.procon.org

    Contact:
    Kamy Akhavan, Managing Editor
    kamy@procon.org
    (310) 587-1407


'/>"/>
SOURCE ProCon.org
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Insurance Industry Contributions to Politicians Block Regulation, Affordability in Health Care Debate, Says FTCR
2. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
3. Docs Debate Drugs vs. Surgery for Angina
4. Doctors Debate Drugs vs. Surgery for Angina
5. New study likely to fuel debate over annual physical exams
6. Post-Debate Statement From AARP Spokesperson Drew Nannis
7. Study fuels debate over whether exercise and body size influence ovarian cancer risk
8. Post-Debate Statement from AARP Board Member Joyce Payne
9. Long Term Care Leader Applauds Clinton for Bringing Critical Issue of Senior Care into the Presidential Debate
10. Mayo Clinic Proceedings provides forum for debate about capital punishment
11. Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post-Acute Care Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Clarion Safety Systems ... safety labels , has been featured in the National Electrical Manufacturers Association’s (NEMA) ... provides electroindustry professionals with manufacturer, regulatory, and standardization news. The publication is a ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers from Catholic ... designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The data, presented ... in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event rates over ...
(Date:5/24/2016)... ... May 24, 2016 , ... Applications ... multiplex immunoassays are widely used for cell and protein analysis. Keeping updated on ... quality and efficiency in these areas. , LabRoots introduces a new complementary ...
(Date:5/23/2016)... ... ... Edward D. Buckingham, M.D . is excited announce that he has been ... out by the National Consumer Advisory Board to honor excellence in medicine. Only doctors ... award. , The National Consumer Advisory Board (NCAB) is a private organization created to ...
(Date:5/23/2016)... TX (PRWEB) , ... May 23, 2016 , ... ... to announce the participation of high-level representatives from the Japan PMDA, US FDA, ... discussions will address how CDISC standards help format data from clinical trials so ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Een app die artsen over ... patiënten kunnen behandelen, hun kennis kunnen delen en van ... nieuwe en revolutionaire MDLinking App, ontwikkeld door een internationale ... Hans Flu en oncologisch chirurg dr. Gijs van ... wordt op dinsdag 24 mei officieel gepresenteerd op het ...
(Date:5/23/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today the ... The hands-on learning experience is a 12-week summer program, ... Fellowship and Internship programs bring participants ... interns are provided optional housing free of charge through ... the Riverfront Residence Hall to foster communication and collaboration ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
Breaking Medicine Technology: